Emergency room trial tests new drug to rescue patients from deadly shock
NCT ID NCT06693726
Summary
This small pilot study is testing whether giving a medication called angiotensin II early in the emergency department is practical and helpful for patients with septic shock—a life-threatening condition where blood pressure drops dangerously low. The study will enroll 20 adults who need medication to support their blood pressure despite receiving fluids. Researchers will see if adding angiotensin II helps reduce the need for other blood pressure medications and stabilizes patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa Hospitals and Clinics
RECRUITINGIowa City, Iowa, 52242, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.